Clinical Trial Update: Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated the use of sargramostim after bone marrow transplantation in patients with myelodysplastic syndromes; the study has been comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• sargramostim (sargramostim)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 2 | Status: COMPLETED